Takeda Pharmaceutical Co. Ltd. - Begin Period Cashflow

Takeda Pharmaceutical Co. Ltd.'s Fiscal Year is From April To March - All Figures are in JPY, Trillions.

The item "Begin-Period-Cashflow" stands at 1.94 Trillion Japanese Yens for the trailing twelve months (TTM) period ending 09/30/2025.

Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.35 Trillion JPY for the item "Begin Period Cashflow" represents an increase of 49.74 percent compared to it's first quarter result.

Also, Takeda Pharmaceutical Co. Ltd.'s second quarter result of 0.35 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -56.48 percent compared to it's second quarter result of last year.

Looking again at the trailing twelve months series (TTM), Takeda Pharmaceutical Co. Ltd.'s second quarter result of 1.94 Trillion JPY for the item "Begin Period Cashflow" represents a decrease of -19.00 percent compared to it's first quarter result.


Regarding the One-Year-Change of the series, the current value constitutes an increase of 19.87 percent compared to the value the year prior.
The 1 year change in percent is 19.87.
The 3 year change in percent is -31.51.
The 5 year change in percent is -17.20.
The 10 year change in percent is -28.12.

The Serie's long term average value is 2.11 Trillion Japanese Yens. It's latest available value, on 09/30/2025, is 8.18 percent lower, compared to it's long term average value.
The Serie's change in percent from it's minimum value, on 06/30/2013, to it's latest available value, on 09/30/2025, is +255.02%.
The Serie's change in percent from it's maximum value, on 12/31/2022, to it's latest available value, on 09/30/2025, is -35.83%.